Peculiarities of toxic effects produced by aluminum oxide nano- and microparticles under multiple inhalation exposure
- Authors: Zemlyanova M.A.1,2,3, Zaitseva N.V.1,4, Stepankov M.S.1
-
Affiliations:
- Federal Scientific Center for Medical and Preventive Health Risk Management Technologies
- Perm State National Research University
- Perm National Research Polytechnic University
- Russian Academy of Sciences
- Issue: Vol 102, No 5 (2023)
- Pages: 502-508
- Section: PREVENTIVE TOXICOLOGY AND HYGIENIC STANDARTIZATION
- Published: 23.06.2023
- URL: https://rjsvd.com/0016-9900/article/view/638570
- DOI: https://doi.org/10.47470/0016-9900-2023-102-5-502-508
- EDN: https://elibrary.ru/zhlqrj
- ID: 638570
Cite item
Full Text
Abstract
Introduction. Aluminum oxide nanoparticles (Al2O3 NPs) are widely used in nanotechnologies employed in various branches including chemical, food, and medical industry and perfume and cosmetics production. This high demand for Al2O3 NPs, given the wide-scale development of nanoindustries, can, in its turn, lead to ambient air pollution that creates public health risks under long-term exposure to it. Given that, it seems relevant to perform profound investigation with its focus on pathogenetic features of toxic effects produced by these nanoparticles and comparatively analyze them with effects produced by a micro-sized chemical analog under inhalation exposure to introduce more effective prevention.
Materials and methods. We examined chemical properties of Al2O3, nano- and microparticles (MPs) in an experiment on Wistar rats, comparatively analyzed the results and described pathogenetic features of toxic effects produced by the examined particles under multiple inhalation exposure.
Results. The examined samples were a nanomaterial judging by such parameters as particle size, shape, surface area, and total pore volume. They differed substantially from their micro-sized analog. Exposure to Al2O3 NPs causes more pronounced changes in the behaviour of rats relative to MPs. Under exposure to Al2O3 NPs, aluminum concentrations were statistically significantly by 1.62–55.2 times higher in the lungs, liver, brain and blood. The concentration of the examined elements was by 1.55–7.65 times higher in these organs as compared to exposure to the micro-sized particles. Exposure to Al2O3 NPs induced changes in biochemical indicators of negative effects against the control (exposure to micro-sized particles). We established higher activity of ALT, AST, AP, LDH, and elevated levels of direct bilirubin, GABA, glutamine acid, and MDA against the same indicators in the control group. Pathomorphological changes were identified in the lungs, brain, heart, and liver under exposure to Al2O3 NPs whereas exposure to the micro-sized analog induced such changes only in the lungs. Exposure to NPs induced more apparent changes in tissue structures in many organs.
Limitations. The study involved only multiple inhalation exposure to Al2O3 NPs and MPs in an experiment on Wistar rats.
Conclusion. Al2O3 NPs are more toxic than their micro-sized chemical analog; this is evidenced by a greater number of organs where bioaccumulation occurs, more apparent pathomorphological changes and pathological functional disorders. The study results should be considered when developing hygienic recommendations aimed at preventing and minimizing negative effects produced by Al2O3 NPs on human health.
Compliance with ethical standards. The study was accomplished in accordance with the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (ETS No. 123) and requirements of the Local Committee on Ethics of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies (the Meeting Report No. 5 issued on January 20, 2021).
Contribution:
Zemlyanova М.А. — the study concept and design, data analysis, writing;
Zaitseva N.V. — the study concept and design, statistical data analysis, editing;
Stepankov М.S. — data collection and analysis.
All the authors have approved the final variant of the article and bear full responsibility for its integrity.
Conflict of interest. The authors declare no conflict of interest.
Acknowledgement. The research was granted financial support from the federal budget.
Received: March 31, 2023 / Accepted: May 31, 2023 / Published: June 20, 2023
About the authors
Marina A. Zemlyanova
Federal Scientific Center for Medical and Preventive Health Risk Management Technologies; Perm State National Research University; Perm National Research Polytechnic University
Author for correspondence.
Email: zem@fcrisk.ru
MD, PhD, DSci, Professor, Head of the Department of Biochemical and Сytogenetic Diagnostics of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, 614045, Russian Federation.
e-mail: zem@fcrisk.ru
Russian FederationNina V. Zaitseva
Federal Scientific Center for Medical and Preventive Health Risk Management Technologies; Russian Academy of Sciences
Email: noemail@neicon.ru
Russian Federation
Mark S. Stepankov
Federal Scientific Center for Medical and Preventive Health Risk Management Technologies
Email: noemail@neicon.ru
Russian Federation
References
- GlobeNewswire. Research and Markets. Global nanomaterials market (2021 to 2029) – featuring BASF, Bayer and Chasm Technologies among others. Available at: https://www.globenewswire.com/news-release/2021/05/18/2231307/28124/en/Global-Nanomaterials-Market-2021-to-2029-Featuring-BASF-Bayer-and-Chasm-Technologies-Among-Others.html
- Research and Markets. Nanotechnology market – size, share, COVID impact analysis and forecast to 2027; 2021. Available at: https://www.researchandmarkets.com/reports/5308793/2021-nanotechnology-market-size-share-covid
- Piracha S., Saleem S. Nanoparticle: role in chemical industries, potential sources and chemical catalysis applications. Sch. Int. J. Chem. Mat. Sci. 2021; 4(4): 40–5. https://doi.org/10.36348/sijcms.2021.v04i04.006
- Shafiq M., Anjum S., Hano C., Anjum I., Abbasi B.H. An overview of the applications of nanomaterials and nanodevices in the food industry. Foods. 2020; 9(2): 148. https://doi.org/10.3390/foods9020148
- Shafique M., Luo X. Nanotechnology in transportation vehicles: an overview of its applications, environmental, health and safety concerns. Materials (Basel). 2019; 12(15): 2493. https://doi.org/10.3390/ma12152493
- Salata O. Applications of nanoparticles in biology and medicine. J. Nanobiotechnology. 2004; 2(1): 3. https://doi.org/10.1186/1477-3155-2-3
- Liu X., Luo L., Ding Y., Xu Y. Amperometric biosensors based on alumina nanoparticles-chitosan-horseradish peroxidase nanobiocomposites for the determination of phenolic compounds. Analyst. 2011; 136(4): 696–701. https://doi.org/10.1039/c0an00752h
- Robertson T.A., Sanchez W.Y., Roberts M.S. Are commercially available nanoparticles safe when applied to the skin? J. Biomed. Nanotechnol. 2010; 6(5): 452–68. https://doi.org/10.1166/jbn.2010.1145
- Krewski D., Yokel R.A., Nieboer E., Borchelt D., Cohen J., Harry J., et al. Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J. Toxicol. Environ. Health B. Crit. Rev. 2007; 10(Suppl. 1): 1–269. https://doi.org/10.1080/10937400701597766
- Arul Prakash F., Dushendra Babu G.J., Lavanya M. Toxicity studies of aluminium oxide nanoparticles in cell lines. Int. J. Nanotechnol. Appl. 2011; 5(2): 99–107.
- Bahadar H., Maqbool F., Niaz K., Abdollahi M. Toxicity of nanoparticles and an overview of current experimental models. Iran. Biomed. J. 2016; 20(1): 1–11. https://doi.org/10.7508/ibj.2016.01.001
- Chen L., Yokel R.A., Hennig B., Toborek M. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J. Neuroimmune Pharmacol. 2008; 3(4): 286–95. https://doi.org/10.1007/s11481-008-9131-5
- El-Hussainy M.A., Hussein A.M., Abdel-Aziz A., El-Mehasseb I. Effects of aluminum oxide (Al2O3) nanoparticles on ECG, myocardial inflammatory cytokines, redox state, and connexin 43 and lipid profile in rats: possible cardioprotective effect of gallic acid. Can. J. Physiol. Pharmacol. 2016; 94(8): 868–78. https://doi.org/10.1139/cjpp-2015-0446
- Balasubramanyam A., Sailaja N., Mahboob M., Rahman M.F., Hussain S.M., Grover P. In vivo genotoxicity assessment of aluminium oxide nanomaterials in rat peripheral blood cells using the comet assay and micronucleus test. Mutagenesis. 2009; 24(3): 245–51. https://doi.org/10.1093/mutage/gep003
- Pauluhn J. Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol. Sci. 2009; 109(1): 152–67. https://doi.org/10.1093/toxsci/kfp046
- Zaytseva N.V., Zemlyanova M.A., Stepankov M.S., Ignatova A.M. Scientific forecasting of toxicity and evaluation of hazard potential of aluminum oxide nanoparticles for human health. Ekologiya cheloveka. 2018; (5): 9–15. https://doi.org/10.33396/1728-0869-2018-5-9-15 https://elibrary.ru/xnzkzv (in Russian)
- Gregg S., Sing K. Adsorption, Surface Area and Porosity. London: Academic Press Inc.; 1982. (in Russian)
- Barrett E.P., Joyner L.G., Halenda P.P. The determination of pore volume and area distributions in porous substances. I. Computations from nitrogen isotherms. J. Am. Chem. Soc. 1951; 73: 373–80. https://doi.org/10.1021/ja01145a126
- Zhang N., Xiong G., Liu Z. Toxicity of metal-based nanoparticles: Challenges in the nano era. Front. Bioeng. Biotechnol. 2022; 10: 1001572. https://doi.org/10.3389/fbioe.2022.1001572
- Chen L., Yokel R.A., Hennig B., Toborek M. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J. Neuroimmune. Pharmacol. 2008; 3(4): 286–95. https://doi.org/10.1007/s11481-008-9131-5
- Liu H., Zhang W., Fang Y., Yang H., Tian L., Li K., et al. Neurotoxicity of aluminum oxide nanoparticles and their mechanistic role in dopaminergic neuron injury involving p53-related pathways. J. Hazard. Mater. 2020; 392: 122312. https://doi.org/10.1016/j.jhazmat.2020.122312
- Pham-Huy L.A., He H., Pham-Huy C. Free radicals, antioxidants in disease and health. Int. J. Biomed. Sci. 2008; 4(2): 89–96.
- Phaniendra A., Jestadi D.B., Periyasamy L. Free radicals: properties, sources, targets, and their implication in various diseases. Indian J. Clin. Biochem. 2015; 30(1): 11–26. https://doi.org/10.1007/s12291-014-0446-0
- Arul Prakash F., Dushendra Babu G.J., Lavanya M. Toxicity studies of aluminium oxide nanoparticles in cell lines. Int. J. Nanotechnol. Appl. 2011; 5(2): 99–107.
- Sirajuddin A., Raparia K., Lewis V.A., Franks T.J., Dhand S., Galvin J.R., et al. Primary Pulmonary Lymphoid Lesions: Radiologic and Pathologic Findings. Radiographics. 2016; 36(1): 53–70. https://doi.org/10.1148/rg.2016140339
- Kaptein F.H.J., Kroft L.J.M., Hammerschlag G., Ninaber M.K., Bauer M.P., Huisman M.V., et al. Pulmonary infarction in acute pulmonary embolism. Thromb. Res. 2021; 202: 162–9. https://doi.org/10.1016/j.thromres.2021.03.022
- Al-Mufti F., Amuluru K., Smith B., Damodara N., El-Ghanem M., Singh I.P., et al. Emerging markers of early brain injury and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. World Neurosurg. 2017; 107: 148–59. https://doi.org/10.1016/j.wneu.2017.07.114
- Suarez J.I., Tarr R.W., Selman W.R. Aneurysmal subarachnoid hemorrhage. N. Engl. J. Med. 2006; 354(4): 387–96. https://doi.org/10.1056/nejmra052732
- Sehba F.A., Hou J., Pluta R.M., Zhang J.H. The importance of early brain injury after subarachnoid hemorrhage. Prog. Neurobiol. 2012; 97(1): 14–37. https://doi.org/10.1016/j.pneurobio.2012.02.003
- Fujii M., Yan J., Rolland W.B., Soejima Y., Caner B., Zhang J.H. Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl. Stroke Res. 2013; 4(4): 432–46. https://doi.org/10.1007/s12975-013-0257-2
- Ciurea A.V., Palade C., Voinescu D., Nica D.A. Subarachnoid hemorrhage and cerebral vasospasm – literature review. J. Med. Life. 2013; 6(2): 120–5.
- Claassen J., Bernardini G.L., Kreiter K., Bates J., Du Y.E., Copeland D., et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001; 32(9): 2012–20. https://doi.org/10.1161/hs0901.095677
- Tang W.K., Wang L., Tsoi K.K.F., Barrash J., Kim J.S. Personality changes after subarachnoid hemorrhage: A systematic review and meta-analysis. J. Psychosom. Res. 2022; 156: 110762. https://doi.org/10.1016/j.jpsychores.2022.110762
- Tang W.K., Wang L., Kwok Chu Wong G., Ungvari G.S., Yasuno F., Tsoi K.K.F., et al. Depression after subarachnoid hemorrhage: a systematic review. J. Stroke. 2020; 22(1): 11–28. https://doi.org/10.5853/jos.2019.02103
- M’rad I., Jeljeli M., Rihane N., Hilber P., Sakly M., Amara S. Aluminium oxide nanoparticles compromise spatial learning and memory performance in rats. EXCLI J. 2018; 17: 200–10. https://doi.org/10.17179/excli2017-1050
- M’rad I., Sakly M., Amara S. Aluminum oxide nanoparticles induced cognitive deficits and oxidative stress in frontal cortex and cerebellum of rat. Adv. J. Toxicol. Curr. Res. 2017; 1(1): 7–14.
- Celis M.E., Torre E. Measurement of grooming behavior. Methods Neurosci. 1993; 14: 359–78.
- Nazarenko G.I., Kishkun A.A. Clinical Evaluation of Laboratory Results [Klinicheskaya otsenka rezul’tatov laboratornykh issledovaniy]. Moscow: Meditsina; 2006. (in Russian)
Supplementary files
